{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:17:03Z","timestamp":1785536223274,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272886"],"award-info":[{"award-number":["82272886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200484"],"award-info":[{"award-number":["82200484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2025AHGXZK30098"],"award-info":[{"award-number":["2025AHGXZK30098"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2023AH030115"],"award-info":[{"award-number":["2023AH030115"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpet.2026.104320","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:08:33Z","timestamp":1774310913000},"page":"104320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["SOX11-mediated CXCL10\/CXCR3 activation promotes neuroendocrine prostate cancer"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7788-931X","authenticated-orcid":false,"given":"Hekang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8137-4456","authenticated-orcid":false,"given":"Qingwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpet.2026.104320_bib1","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.jpet.2026.104320_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","article-title":"Updates to Advanced Prostate Cancer: aua\/suo Guideline (2023)","volume":"209","author":"Lowrance","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.jpet.2026.104320_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of Advanced Prostate Cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pcmedi\/pbab003","article-title":"Neuroendocrine cells of the prostate: histology, biological functions, and molecular mechanisms","volume":"4","author":"Butler","year":"2021","journal-title":"Precis Clin Med"},{"issue":"24","key":"10.1016\/j.jpet.2026.104320_bib5","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: a Multi-institutional Prospective Study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6320","key":"10.1016\/j.jpet.2026.104320_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41467-019-14219-6","article-title":"MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer","volume":"11","author":"Yasumizu","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jpet.2026.104320_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","article-title":"Molecular events in neuroendocrine prostate cancer development","volume":"18","author":"Wang","year":"2021","journal-title":"Nat Rev Urol"},{"issue":"8","key":"10.1016\/j.jpet.2026.104320_bib9","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41388-021-02157-x","article-title":"SOX2 mediates metabolic reprogramming of prostate cancer cells","volume":"41","author":"de Wet","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41467-023-36735-2","article-title":"SOX11 regulates SWI\/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry","volume":"14","author":"Decaesteker","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib11","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-024-47166-y","article-title":"Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation","volume":"15","author":"Banerjee","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-019-1146-7","article-title":"Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8","volume":"38","author":"Huang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"Pt 1","key":"10.1016\/j.jpet.2026.104320_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2020.06.015","article-title":"Regulatory roles for SOX11 in development, stem cells and cancer","volume":"67","author":"Tsang","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104320_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.jpet.2026.104320_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.104320_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran","year":"2011","journal-title":"Cancer Discov"},{"issue":"11","key":"10.1016\/j.jpet.2026.104320_bib17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ccell.2022.10.011","article-title":"FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer","volume":"40","author":"Han","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104320_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","article-title":"Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy","volume":"81","author":"Cheng","year":"2022","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.jpet.2026.104320_bib21","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104320_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7150\/thno.92336","article-title":"Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.jpet.2026.104320_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jpet.2026.104320_bib24","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","article-title":"Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104320_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12264-020-00608-1","article-title":"CXCL10\/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice","volume":"37","author":"Kong","year":"2021","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jpet.2026.104320_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100690","article-title":"The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma","volume":"52","author":"Gyau","year":"2025","journal-title":"J Bone Oncol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104320_bib27","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.bmcl.2007.03.106","article-title":"Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3","volume":"17","author":"Johnson","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.jpet.2026.104320_bib28","article-title":"Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: a Literature Review","volume":"13","author":"Dhavale","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13059-025-03623-5","article-title":"Transcriptional analysis of metastatic hormone-na\u00efve prostate cancer primary tumor biopsies reveals a relevant role for SOX11 in prostate cancer cell dissemination","volume":"26","author":"Martin-Martin","year":"2025","journal-title":"Genome Biol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104320_bib30","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104320_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jpet.2026.104320_bib32","article-title":"The role of CXCR3 and its ligands in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104320_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13568-025-01989-0","article-title":"Integrative mendelian randomization and multi-omics analysis reveal a gut microbiota-metabolite-CXCL10 axis in breast cancer","volume":"15","author":"Qu","year":"2025","journal-title":"AMB Express"},{"key":"10.1016\/j.jpet.2026.104320_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopha.2016.04.069","article-title":"CXCL10\/CXCR3 axis promotes the invasion of gastric cancer via PI3K\/AKT pathway-dependent MMPs production","volume":"82","author":"Zhou","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.jpet.2026.104320_bib35","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.7150\/ijbs.61350","article-title":"TNF-\u03b1 augments CXCL10\/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell","volume":"17","author":"Wang","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10.1016\/j.jpet.2026.104320_bib36","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:03:48Z","timestamp":1779955428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526005197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022356526005197"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104320","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOX11-mediated CXCL10\/CXCR3 activation promotes neuroendocrine prostate cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104320"}}